Obesity and its linked morbidity and mortality is a significant public health challenge on a global scale and places a burden not only on the individual but also on society as a whole. This Mini-Guide presents key themes relating to this challenge, including the means of measuring obesity, the most recent prevalence and trends, the health consequences and causes of obesity along with approaches to counter obesity both at an individual and a population level.
Understanding is facilitated through:
- Case Studies
- Boxed examples
- Thinking Points
- Summary Points at ends of chapters.
- Links to webpages, resources and further reading.
Inhaltsverzeichnis
1;Front Cover;1 2;Public Health Mini-Guide: Obesity;4 3;Copyright;5 4;Contents;6 5;Series Info;7 6;Series preface;8 6.1;What the Public Health Mini-Guides provide ;8 6.2;References;9 7;Preface;10 8;Chapter 1: Defining the obesity problem;12 8.1;What is obesity?;12 8.2;Measuring obesity;12 8.2.1;Surveillance programmes;12 8.2.2;Measurement of obesity;14 8.2.2.1;Common measures of obesity;14 8.2.2.1.1;Body Mass Index (BMI);14 8.2.2.1.1.1;Weaknesses and strengths of BMI;15 8.2.2.1.2;Other height to weight indices;16 8.2.2.1.3;Abdominal circumference measurements;16 8.2.2.1.3.1;Weaknesses and strengths of abdominal circumference measures;18 8.2.2.1.4;Skinfold estimation methods;19 8.2.2.1.4.1;Weaknesses and strengths of skinfold estimation methods;19 8.2.2.1.5;Bio Impedance Analysis;20 8.2.2.1.5.1;Weaknesses and strengths of Bio Impedance Analysis;20 8.2.2.2;Technical measures of obesity;22 8.2.2.2.1;Body density measurements;22 8.2.2.2.1.1;Weaknesses and strengths of body density measures;22 8.2.2.2.2;Chemical measures;23 8.2.2.2.2.1;Weaknesses and strengths of chemical measures;23 8.2.2.2.3;Internal scanning;23 8.2.2.2.3.1;Weaknesses and strengths of internal scans;24 8.2.2.2.4;Body imaging;24 8.2.2.2.4.1;Weaknesses and strengths of imaging;25 8.2.3;Classifying obesity in children;26 8.2.3.1;1. British 1990 growth reference (UK90);27 8.2.3.2;2. International Obesity Task Force (IOTF) cut-offs;27 8.2.3.3;3. World Health Organization (WHO) Child Growth Standard;28 8.2.3.4;4. World Health Organization (WHO) 2007 growth reference;28 8.2.3.5;United States Centers for Disease Control and Prevention (CDC) 2000 growth reference;29 8.2.3.6;Adiposity rebound;29 8.3;Web pages and resources;31 8.4;Further reading;31 9;Chapter 2: Obesity prevalence and trends;33 9.1;UK and Ireland prevalence figures;33 9.1.1;England;33 9.1.1.1;Adult prevalence;33 9.1.1.2;Child prevalence;33 9.1.2;Scotland;35 9.1.2.1;Adult prevalence;35 9.1.2.2;Child prevalence;35 9.1.3;Wales;35 9.1.3.1;Adult preva
lence;35 9.1.3.2;Child prevalence;35 9.1.4;Northern Ireland;35 9.1.4.1;Adult prevalence;35 9.1.4.2;Child prevalence;35 9.1.5;Ireland;36 9.1.5.1;Adult prevalence;36 9.1.5.2;Child prevalence;36 9.1.6;Access to UK data on obesity;37 9.2;North America;37 9.2.1;United States of America;37 9.2.1.1;Adult prevalence;37 9.2.1.2;Child prevalence;38 9.2.2;Canada;38 9.2.2.1;Adult prevalence;38 9.2.2.2;Child prevalence;38 9.3;Australasia;38 9.3.1;Australia;38 9.3.1.1;Adult prevalence;38 9.3.1.2;Child prevalence;39 9.3.2;New Zealand;39 9.3.2.1;Adult prevalence;39 9.3.2.2;Child prevalence;39 9.4;International prevalence of obesity;40 9.4.1;WHO Global Health Observatory (apps.who.int/ghodata);40 9.4.1.1;Details;40 9.4.2;WHO Global Infobase ( https://apps.who.int/infobase/Comparisons.aspx);41 9.4.2.1;Details;41 9.4.3;WHO Global database on body mass index (http://apps.who.int/bmi);41 9.4.3.1;Details;41 9.4.4;OECD StatExtracts Health Stats (www.oecd.org);42 9.4.4.1;Details;42 9.4.5;IASO Obesity Data (www.iaso.org);42 9.4.5.1;Details;42 9.5;Adult international prevalence;42 9.6;Child international prevalence;44 9.7;Adult international trends;45 9.8;Predicting future trends;48 9.9;Prevalence within countries;50 9.9.1;Sex;50 9.9.2;Age;50 9.9.3;Ethnicity;51 9.9.4;Deprivation;53 9.9.5;Regions;56 9.10;Web pages and resources;58 9.11;Further reading;58 10;Chapter 3: The health consequences of obesity;59 10.1;Difficulties evaluating the health consequences of obesity;59 10.2;Fat as an active tissue;60 10.3;Abdominal fat;60 10.4;Types of ill health associated with obesity;61 10.5;Circulatory system;61 10.5.1;Hypertension;61 10.5.2;Elevated cholesterol;62 10.5.3;CVDs;62 10.6;Cancer;63 10.7;Metabolic;64 10.7.1;Diabetes;64 10.7.2;Metabolic syndrome;64 10.8;Gastrointestinal and liver;65 10.8.1;Gallstones;65 10.8.2;Pancreatitis;66 10.8.3;Gastroesophageal reflux disease (GERD);66 10.8.4;Non-alcoholic liver disease;67 10.9;Musculoskeletal;67 10.9.1;Joint pain;67 10.9.2;Osteoarthritis;68 10.9.3;Gout;
68 10.9.4;Other musculoskeletal conditions;68 10.10;Respiratory system;68 10.10.1;Respiratory function;68 10.10.2;Obstructive sleep apnoea;69 10.10.3;Asthma;69 10.10.4;Other respiratory conditions;69 10.11;Reproductive health;69 10.11.1;Polycystic ovary syndrome;69 10.11.2;Female fertility;69 10.11.3;Male fertility;70 10.11.4;Erectile dysfunction;70 10.11.5;Contraceptive failure;70 10.11.6;Pregnancy;70 10.12;Urology;71 10.12.1;Urinary incontinence;71 10.12.2;Benign prostatic hyperplasia;71 10.12.3;Kidney stones;71 10.12.4;Chronic kidney disease;71 10.13;Psychological and social difficulties;71 10.13.1;Stigmatisation;71 10.13.2;Depression;72 10.13.3;Dementia;72 10.14;Dermatology;72 10.14.1;Skin infections;72 10.14.2;Acanthosis nigricans;72 10.14.3;Psoriasis;72 10.14.4;Pressure sores;73 10.14.5;Stretch marks;73 10.15;Differences in risk between ethnic group;73 10.16;Children and adolescents;74 10.17;Mortality;74 10.18;Societal impact of obesity;75 10.19;Economic impact of obesity;75 10.20;Web pages and resources;77 10.21;Further reading;77 11;Chapter 4: Causes of obesity;78 11.1;Energy balance;78 11.1.1;Energy intake;78 11.2;Regulation of energy intake;79 11.3;Energy expenditure;80 11.4;Influences on obesity;81 11.5;Individual influences on obesity;82 11.5.1;Biological/genes;82 11.5.1.1;Sex;82 11.5.1.2;Age;83 11.5.1.3;Socioeconomic status;84 11.5.1.4;Ethnicity;85 11.5.1.5;Intrapersonal;86 11.5.1.6;Interpersonal;87 11.5.2;Environmental factors;88 11.5.2.1;Microenvironmental;89 11.5.2.2;Macroenvironmental;90 11.5.3;Economic development;90 11.5.4;Food taxes;90 11.5.5;Urban design;91 11.5.6;Food industry;92 11.6;Web pages and resources;93 11.7;Further reading;93 12;Chapter 5: Individual interventions to treat obesity;95 12.1;Consultation;95 12.1.1;1. Screening to identify risk and willingness to change;96 12.1.2;2. Counselling to provide information and increase motivation;97 12.1.3;3. Referral for those at high risk to intervention;98 12.1.4;4. Follow-up to track progres
s and overcome barriers;98 12.2;Adult interventions;98 12.2.1;Non-clinical interventions targeting obesity;99 12.2.2;Diet;99 12.2.2.1;Reduced-energy diet (RED);101 12.2.2.2;Low-energy diet (LED);101 12.2.2.3;Very-low-energy diets (VLED);101 12.2.2.4;Fixed-energy-deficit (FED);101 12.2.3;Physical activity;101 12.2.4;Behavioural;102 12.3;Child interventions;103 12.4;Drug therapy;105 12.4.1;Anti-obesity drugs;106 12.4.1.1;Lipase inhibitors;107 12.4.1.2;Appetite suppressants;108 12.4.2;Surgical intervention;108 12.5;Web pages and resources;113 12.6;Further reading;113 13;Chapter 6: Population approaches to preventing obesity;114 13.1;Population approach;114 13.1.1;Targeting, development and monitoring;115 13.1.1.1;Targeting;115 13.1.1.2;Development;116 13.1.1.3;Monitoring;116 13.1.2;Multifactorial approach;117 13.1.3;Policy;117 13.1.4;Information;119 13.1.4.1;Fiscal intervention;120 13.1.4.2;Legislation;121 13.1.5;Stakeholders;122 13.1.5.1;National government;122 13.1.5.2;Local government;122 13.1.5.3;Health and social services;123 13.1.5.4;International agencies;123 13.1.5.5;Private sector;123 13.1.5.6;Media;124 13.1.5.7;Other stakeholders;124 13.1.6;Settings;124 13.1.6.1;Schools;124 13.1.6.2;Work place;125 13.1.6.3;Communities;125 13.1.7;Web pages and resources;128 13.1.8;Further reading;128 14;References;130 14.1;Chapter 1;130 14.2;Chapter 2;132 14.3;Chapter 3;133 14.4;Chapter 4;134 14.5;Chapter 5;136 14.6;Chapter 6;137 15;Index;140 16;References;148 16.1;Chapter 1;148 16.2;Chapter 2;154 16.3;Chapter 3;157 16.4;Chapter 4;165 16.5;Chapter 5;176 16.6;Chapter 6;182